Self-dissolving micropile array chip as percutaneous delivery system of protein drug

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 4, 2010, Pages 683-690

  Ito, Yukako ^a   Hasegawa, Ryo ^a   Fukushima, Keizo ^a   Sugioka, Nobuyuki ^a   Takada, Kanji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Bioavailability; Erythropoietin; Percutaneous absorption; Self dissolving micropile array chip

Indexed keywords

CHONDROITIN SULFATE; POLYMER; RECOMBINANT ERYTHROPOIETIN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MICROSCOPY; NONHUMAN; PHYSICAL CHEMISTRY; RAT; SELF DISSOLVING MICROPILE ARRAY CHIP; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, CUTANEOUS; ANIMALS; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CHONDROITIN SULFATES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; ERYTHROPOIETIN; MALE; RATS; RATS, WISTAR;

EID: 77950876751     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.683     Document Type: Article

References (33)

1. Barry B., Williams A., Adv. Drug. Deliv. Rev., 56, 603-618 (2003).
2. Mudry B., Guy R. H., Delgado-Charro M. B., Enhancement in Drug Delivery, Chap. 14, ed. by Touitou E., Barry B. W., CRC Press, Boca Raton, 2006, pp. 279-302.
3. Bonner M. C., Barry B., Enhancement in Drug Delivery, Chap. 15, ed. by Touitou E., Barry B. W., CRC Press, Boca Raton, FL, 2006, pp. 303-315.
4. Kost J., Wolloch L., Enhancement in Drug Delivery, Chap. 16, ed. by Touitou E., Barry B. W., CRC Press, Boca Raton, FL, 2006, pp. 317-330.
5. Hikima T., Ohsumi S., Shirouzu K., Tojo K., Biol. Pharm. Bull., 32, 905-909 (2009).
6. Obata Y., Maruyama Y., Takayama K., Pharm. Res., 23, 392-400 (2006).
7. Murthy S. N., Zhao Y. L., Marlan K., Hui S. W., Kazim A. L., Sen A., J. Pharm. Sci., 95, 2041-2050 (2006).
8. Mitragotri S., Blankschtein S. B., Science, 269, 850-853 (1995).
9. Nugroho A. K., Li G. L., Danhof M., Bouwstra J. A., Pharm. Res., 21, 844-850 (2004).
10. Henry S., McAllister D. V., Allen M. G., Prausnitz M. R., J. Pharm. Sci., 187, 922-925 (1998).
11. Teo M. A. L., Shearwood C., Ng K. C., Lu J., Moochhala S., Biomed. Microdevices, 7, 47-52 (2005).
12. Park J. H., Allen M. G., Prausnitz M. R., Pharm. Res., 23, 1008-1019 (2006).
13. Davis S. P., Martanto W., Allen M. G., Prausnitz M. R., IEEE Trans. Biomed. Eng., 52, 909-915 (2005).
14. McAllister D. V., Wang P. M., Davis S. P., Park J. H., Canatella P. J., Allen M. G., Prausnitz M. R., Kaushik S., Hord A. H., Denson D. D., Smitra S., Henry S., Proc. Natl. Acad. Sci. U.S.A., 100, 13755-13760 (2003).
15. Ito Y., Hagiwara E., Saeki A., Sugioka N., Takada K., Eur. J. Pharm. Sci., 29, 82-88, (2006).
16. Ito Y., Ohashi Y., Saeki A., Sugioka N., Takada K., Chem. Pharm. Bull., 56, 243-246 (2008).
17. Ito Y., Yoshimitsu J., Shiroyama K., Sugioka N., Takada K., J. Drug Targeting, 14, 255-262 (2006).
18. Ito Y., Shiroyama K., Yoshimitsu J., Ohashi Y., Sugioka N., Takada K., J. Controlled Release, 121, 176-180 (2007).
19. Ito Y., Saeki A., Shiroyama K., Sugioka N., Takada K., J. Drug Targeting, 16, 243-249 (2008).
20. Ito Y., Ohashi Y., Shiroyama K., Sugioka N., Takada K., Biol. Pharm. Bull., 31, 1631-1633 (2008).
21. Yoshikawa Y., Kato K., Sone H., Takada K., Jpn. J. Clin. Pharmacol., 29, 475-487 (1998).
22. DeFelippis M. R., Bell M. A., Heyob J. A., Storms S. M., Diabet. Technol. Ther., 8, 358-368 (2006).
23. Tokumoto S., Higo N., Sugibayashi K., Int. J. Pharm., 326, 13-19 (2006).
24. Park E. J., Werner J., Smith N. B., Pharm. Res., 24, 1396-1401 (2007).
25. Li Y. Z., Quan Y. S., Zang L., Jin M. N., Kamiyama F., Katsumi H., Yamamoto A., Tsutsumi S., Biol. Pharm. Bull., 31, 1574-1579 (2008).
26. Prausnitz M. R., Bose V. G., Langer R., Weaver J. C., Proc. Natl. Acad. Sci. U.S.A., 90, 10504-10508 (1993).
27. Verbaan F. J., Bal S. M., van den Berg D. J., Dijksman J. A., van Hecke M., Verpoorten H., van den Berg A., Luttge R., Bouwstra J. A., J. Controlled Release, 128, 80-88 (2008).
28. Wermeling D. P., Banks S. L., Hudson D. A., Gill H. S., Gupta J., Prausnitz M. R., et al., Proc. Natl. Acad. Sci. U.S.A., 105, 2058-2063 (2008).
29. Kolli C. S., Banga A. K., Pharm. Res., 25, 104-113 (2008).
30. Ito Y., Yamazaki T., Sugioka N., Takada K., J. Mater. Sci.: Mater. Med., 21, 835-841 (2010).
31. Monteiro-Riviere N. A., Bristol D. G., Manning T. O., Rogers R. A., Riviere J. E., J. Inv. Dermatol., 95, 582-586 (1990).
32. Caspers P. J., Lucassen G. W., Bruining H. A., Puppels G. J., J. Raman Spectrosc., 31, 813-818 (2000).
33. Bauer J., Bahmer F. A., Worl J., Neuhuber W., Schuler G., Fartasch M., J. Inv. Dermatol., 116, 313-318 (2001).